Lifeboat Foundation

For just $25 your name will be converted into cool DNA coding language and placed in the special CellAge time capsule for a future generation to discover!

Your donation could help us to develop cures for age-related diseases, check out the CellAge project on Lifespan.io today.

https://www.lifespan.io/campaigns/cellage-targeting-senescen…c-biology/

Continue reading “For true biologists this is the only way their keyboard works :D” »

Philadelphia, PA, USA / Moscow, Russia — Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, announced the commercial approval of naturally derived Bioquantine food ingredients in the Eurasian Customs Union (formerly known as the Customs Union of Belarus, Kazakhstan, and Russia). Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, collaborated with Bioquark Inc. on the regulatory approvals.

“We are very excited about this successful regulatory approval,” said Ira S. Pastor, CEO, Bioquark Inc. “The commercialization of Bioquantine food ingredients, including functional foods, drinks, and dietary supplements, represents another important step in our continued evolution as a company focused on a broad range of products and services in the regenerative healthcare space.”

Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.

Continue reading “Bioquark Inc. Announces Approval of Bioquantine Food Ingredients in Eurasian Customs Union” »

The race is on to develop anti-ageing treatments, but will they really work? And if they do, will only the rich be to defy the ravages of time?

In Brief

• Microsoft is partnering with a prestigious eye hospital in India to help perfect AI powered computer diagnostics to the field of ophthalmology.
• Artificial intelligence is continually making great strides to integrate more in various healthcare settings, hopefully increasing the quality and availability of patient care.

According to the World Health Organization, an estimated 285 million people are visually impaired, with 39 million living with blindness and the other 246 million having low vision.

In a world of modern technological advancements, visual impairment has been the subject of much medical research. Perhaps the most notable among these are those that use artificial intelligence (AI), specifically through machine learning. Google’s DeepMind has been working with the UK’s National Health Service to do ophthalmology research.

Continue reading “Artificial Intelligence is Helping Restore Vision” »

In Brief CRISPR has opened up limitless avenues for genetic modification. From disease prevention to invasive species control, Jennifer Kahn discusses the discover, application, and implications of gene drives.

Jennifer Kahn, a science journalist for the New York Times, recently did a TED Talk in which she discussed the discovery, application, and implications of a CRISPR gene drive used to make mosquitoes resistant to malaria and other diseases like chikungunya, and Zika.

Continue reading “Gene Editing Can Now Change An Entire Species Forever” »

With wound-healing smart fabrics and enhanced night-vision, researchers are building the next generation of indestructible soldiers.

Brain cancer treated with patient’s own immune cells.

A man with an aggressive cancer in his brain and spine went into remission after doctors dripped his own white blood cells into his brain.

Despite efforts to raise public awareness about the disease, cases of melanoma, the most deadly form of skin cancer, have been on the rise in the United States for years. Now, scientists have discovered a new drug that can stop metastasis of the disease, that is, the development of melanoma cells elsewhere in the body — by as much as 90 percent.

The findings are courtesy of a new study published in the journal Molecular Cancer Therapeutics. For the study, researchers injected immuno-compromised mice with human melanoma cells and exposed them to a man-made, small-molecule drug that targets a gene’s ability to produce RNA molecules (one of the major building blocks of life) and certain proteins found in melanoma tumors. Those genes typically cause the disease to spread, but when they were exposed to the compound, up to 90 percent of the cells were prevented from metastasizing.

The potential drug, known as CCG-203971, is the same as the one the researchers have been studying as a potential treatment for scleroderma, a rare and often fatal autoimmune disease that causes the hardening of skin tissue, lungs, heart, kidneys, and other organs.

Continue reading “Scientists Discover New Drug That Stops the Spread of 90% of Melanoma Cells” »

“By comparing clonal and sexual daughters from the same mothers, we found sexually produced offspring get less sick,” Auld said.

PARIS – From an evolutionary perspective, sexual reproduction could be seen as a nonstarter. Compared to cloning, which also exists in nature, it is a major waste of time and energy.

Think of the ungainly, preening peacock — an easy snack for tigers and wild dogs — strutting his stuff to impress the ladies.

Continue reading “Sex exists to avoid disease, study demonstrates” »